1. Molan A, Nosaka K, Hunter M, Wang W. Global status of Toxoplasma gondii infection: systematic review and prevalence snapshots. Trop Biomed. 2019; 36(4):898-925.
2. Wei HX, Wei SS, Lindsay DS, Peng HJ. A systematic review and meta-analysis of the efficacy of anti-Toxoplasma gondii medicines in humans. PLoS One. 2015; 10(9):e0138204.
3. Soltani S, Foroutan M, Afshari H, Hezarian M, Kahvaz MS. Seroepidemiological evaluation of Toxoplasma gondii immunity among the general population in southwest of Iran. J Parasit Dis.2018; 42(4):636-42.
4. Azami SJ, Teimouri A, Keshavarz H, et al. Curcumin nanoemulsion as a novel chemical for the treatment of acute and chronic toxoplasmosis in mice. Int J Nanomedicine.2018; 13:7363-74.
5. Teimouri A, Goudarzi F, Goudarzi K, et al. Toxoplasma gondii Infection in Immunocompromised Patients in Iran (2013–2022): A Systematic Review and Meta-Analysis. Iran J Parasitol. 2022; 17(4):443-57.
6. Hosseini-Safa A, Shojaee S, Salami SA, et al. Development of High Resolution Melting Analysis as a Diagnostic Tool for Molecular Detection of Toxoplasma Infection in Pregnant Women and HIV Positive Cases. Iran J Public Health.2020; 49(10):1983-91.
7. Zaki L, Ghaffarifar F, Sharifi Z, Horton J, Sadraei J. Effect of Imiquimod on Tachyzoites of Toxoplasma gondii and Infected Macrophages in vitro and in BALB/c Mice. Front Cell Infect Microbiol. 2020; 10:387.
8. Teimouri A, Mohtasebi S, Kazemirad E, Keshavarz H. Role of Toxoplasma gondii IgG avidity testing in discriminating between acute and chronic toxoplasmosis in pregnancy. J Clin Microbiol.2020; 58(9):e00505-20.
9. Ali-Heydari S, Keshavarz H, Shojaee S, Mohebali M . Diagnosis of antigenic markers of acute toxoplasmosis by IgG avidity immunoblotting. Parasite.2013; 20:18.
10. Ahmadpour E, Ebrahimzadeh MA, Sharif M, et al. Anti-Toxoplasma activities of Zea mays and Eryngium caucasicum extracts, in vitro and in vivo. J Pharmacopuncture.2019; 22(3):154-159.
11. Montazeri M, Sharif M, Sarvi S, Mehrzadi S, Ahmadpour E, Daryani A. A systematic review of in vitro and in vivo activities of anti-Toxoplasma drugs and compounds (2006–2016). Front Microbiol. 2017; 8:25.
12. Wang D, Xing M, El-Ashram S, et al. Determination of lumefantrine as an effective drug against Toxoplasma gondii infection–in vitro and in vivo study. Parasitology. 2021; 148(1):122-8.
13. Alnomasy SF. In vitro and in vivo anti-Toxoplasma effects of Allium sativum essential oil against Toxoplasma gondii RH strain. Infect Drug Resist. 2021;14: 5057-68.
14. Adeyemi OS, Murata Y, Sugi T, Han Y, Kato K. Nanoparticles show potential to retard bradyzoites in vitro formation of Toxoplasma gondii. Folia Parasitol (Praha).2019; 66:2019.
15. Vargas Hernandez M, Macias Bobadilla I, Guevara Gonzalez RG, et al. Nanoparticles as potential antivirals in agriculture. Agric.2020; 10(10):444.
16. Sharma R, Garg R, Kumari A. A review on biogenic synthesis, applications and toxicity aspects of zinc oxide nanoparticles. EXCLI J. 2020; 19:1325-40.
17. Nikolova MP, Chavali MS. Metal oxide nanoparticles as biomedical materials. Biomimetics (Basel). 2020; 5(2):27.
18. Siddiqi KS, Husen A. Properties of zinc oxide nanoparticles and their activity against microbes. Nano Res Letters.2018; 13(1):1-13.
19. Gandhi PR, Jayaseelan C, Mary RR, Mathivanan D, Suseem S . Acaricidal, pediculicidal and larvicidal activity of synthesized ZnO nanoparticles using Momordica charantia leaf extract against blood feeding parasites. Exp Parasitol. 2017; 181:47-56.
20. Vaishnav J, Subha V, Kirubanandan S, Arulmozhi M, Renganathan S . Green synthesis of zinc oxide nanoparticles by Celosia argentea and its characterization. J Optoelectron Biomed Mater.2017; 9:59-71.
21. Gaafar M, Mady R, Diab R, Shalaby TI . Chitosan and silver nanoparticles: promising anti-Toxoplasma agents. Exp Parasitol.2014;143:30-8.
22. GabAllah M, Barakat A, Ahmed N, El-Nadi N. Histopathological and biochemical assessment of the therapeutic effect of gold nanoparticles on experimental chronic toxoplasmosis. PUJ. 2021; 14(2):171-7.
23. El-Kady AM, S Hassan A, Mohamed K, et al. Zinc oxide nanoparticles produced by Zingiber officinale ameliorates acute toxoplasmosis-induced pathological and biochemical alterations and reduced parasite burden in mice model. PLoS Negl Trop Dis. 2023 ;17(7):e0011447.
24. Saadatmand M, Al-Awsi GRL, Alanazi AD, et al. Green synthesis of zinc nanoparticles using Lavandula angustifolia Vera. Extract by microwave method and its prophylactic effects on Toxoplasma gondii infection. Saudi J Biologic Sci.2021; 28(11):6454-60.
25. Gauthier C, Griffin G. Using animals in research, testing and teaching. Rev Sci Tech .2005; 24(2):735-45.
26. Albus U. Guide for the care and use of laboratory animals. 8th ed. SAGE: Publications Sage UK: London, England;2012.
27. Teimouri A, Modarressi MH, Shojaee S, et al. Detection of Toxoplasma-specific immunoglobulin G in human sera: performance comparison of in house Dot-ELISA with ECLIA and ELISA. Eur J Clin Microbiol Infect Dis.2018; 37(8):1421-9.
28. Singh J, Kumar S, Alok A, et al. The potential of green synthesized zinc oxide nanoparticles as nutrient source for plant growth. J Clean Prod.2019; 214:1061-1070.
29. Eghbalnia H. Evalution of cytotoxic effects of zinc oxide nanoparticles on tachyzoites of Toxoplasma gondii RH strain in experimental conditions [Master dissertation].School of Public Health, Tehran University of Medical Sciences; 2019.
30. Shojaee S, Firouzeh N, Keshavarz H, Azami SJ, Salimi M, Mohebali M. Nanosilver colloid inhibits Toxoplasma gondii tachyzoites and bradyzoites in vitro. Iran J Parasitol. 2019;14(3):362-67.
31. Abou-El-Naga IF, El Kerdany ED, Mady RF, Shalaby TI, Zaytoun EM. The effect of lopinavir/ritonavir and lopinavir/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis. Parasitol Int. 2017; 66(6):735–747. Epub 2017/08/26.
32. Escalante M, Romarı´s F, Rodrı´guez M, et al. Evaluation of Trichinella spiralis larva group 1 antigens for serodiagnosis of human trichinellosis. J Clin Microbiol. 2004; 42(9):4060–4066. Epub 2004/09/15.
33. Teimouri A, Azami SJ, Keshavarz H, et al. Anti-Toxoplasma activity of various molecular weights and concentrations of chitosan nanoparticles on tachyzoites of RH strain. Int J Nanomedicine.2018;13:1341-51.
34. Delavari M, Dalimi A, Ghaffarifar F, Sadraei J . In vitro study on cytotoxic effects of ZnO nanoparticles on promastigote and amastigote forms of Leishmania major (MRHO/IR/75/ER). Iran J Parasitol. 2014; 9(1):6-13.
35. Najoom S, Fozia F, Ahmad I, et al. Effective Antiplasmodial and Cytotoxic Activities of Synthesized Zinc Oxide Nanoparticles Using Rhazya stricta Leaf Extract. Evid Based Complement Alternat Med. 2021; 2021:5586740.